Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenedrive Regulatory News (GDR)

Share Price Information for Genedrive (GDR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.625
Bid: 1.60
Ask: 1.65
Change: 0.025 (1.56%)
Spread: 0.05 (3.125%)
Open: 1.60
High: 1.675
Low: 1.60
Prev. Close: 1.60
GDR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holdings in Company

6 Feb 2017 17:53

RNS Number : 1657W
Genedrive PLC
06 February 2017
 

 

For filings with the FCA include the annex

For filings with issuer exclude the annex

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

Genedrive plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

Prudential plc group of companies

4. Full name of shareholder(s)  (if different from 3.):iv

 

Prudential plc

The Prudential Assurance Company Limited

Prudential Pensions Limited

M&G Group Limited

M&G Limited

M&G Investment Management Limited

 

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

03 February 2017

6. Date on which issuer notified:

06 February 2017

7. Threshold(s) that is/are crossed orreached: vi, vii

6%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

ORD GBP0.015

GB00B1VKB244

Below 5%

Below 5%

1,248,490

0

1,248,490

0

6.68%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

1,248,490

6.68%

 

 

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

Prudential plc (parent Company) - 1,248,490 (6.68%)

The Prudential Assurance Company Limited (wholly owned subsidiary of Prudential plc) - 1,248,490 (6.68%)

Prudential Pensions Limited (wholly owned subsidiary The Prudential Assurance Company Limited) - 1,248,490 (6.68%)

M&G Group Limited (wholly owned subsidiary of Prudential plc) - 1,248,490 (6.68%)

M&G Investment Management Limited (wholly owned subsidiary of M&G Limited) - 1,248,490 (6.68%)

M&G Limited (wholly owned subsidiary of M&G Group Limited) - 1,248,490 (6.68%)

 

Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will cease to hold:

N/A

12. Date on which proxy holder will cease to hold voting rights:

N/A

13. Additional information:

14. Contact name:

John Baker / Owen Smith / James Todd

M&G Investment Management Limited

15. Contact telephone number:

020 7548 2561 / 020 7004 4517 / 020 7548 2293

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLOKADQOBKDCBK
Date   Source Headline
15th Apr 20131:39 pmRNSHolding(s) in Company
8th Apr 20134:08 pmRNSDirector/PDMR Shareholding
26th Mar 20137:01 amRNSSenior Executive Incentive Package
26th Mar 20137:00 amRNSHalf Yearly Report
1st Mar 201310:06 amRNSNotice of Results
22nd Feb 20139:13 amRNSAdditional Listing
20th Feb 20139:39 amRNSHolding(s) in Company
20th Feb 20139:35 amRNSHolding(s) in Company
10th Jan 20134:36 pmRNSDirector/PDMR Shareholding
9th Jan 20132:26 pmRNSHolding(s) in Company
17th Dec 20126:13 pmRNSDirector/PDMR Shareholding
13th Dec 20123:24 pmRNSResult of AGM
10th Dec 20129:45 amRNSHolding(s) in Company
7th Dec 20121:00 pmRNSCash Placing
21st Nov 20128:18 amRNSAnnual Report & Accounts and Notice of AGM
25th Oct 201210:54 amRNSHolding(s) in Company
24th Oct 201212:19 pmRNSHolding(s) in Company
24th Oct 20129:51 amRNSHolding(s) in Company
16th Oct 20127:00 amRNSFinal Results
4th Oct 20123:55 pmRNSDirector/PDMR Shareholding
10th Sep 20123:19 pmRNSPreliminary Results Date
6th Aug 20127:00 amRNSPre-Close Trading Update
3rd Aug 201211:58 amRNSProfessor Chris Potten
27th Jul 20124:09 pmRNSDirector's Shareholding and Additional Listing
10th Jul 20129:17 amRNSDirector/PDMR Shareholding
5th Jul 20127:00 amRNSTuberculosis test gains CE-IVD registration
3rd Apr 20124:53 pmRNSDirector/PDMR Shareholding
27th Mar 20129:13 amRNSAdditional Listing
14th Mar 20127:00 amRNSHalf Yearly Report
5th Mar 20127:00 amRNSEpistem Signs TB Channel Partner Agreement
22nd Feb 20128:18 amRNSHolding(s) in Company
21st Feb 20127:00 amRNSNotice of Results
20th Feb 20126:28 pmRNSHolding(s) in Company
10th Feb 20127:00 amRNSHolding(s) in Company
10th Jan 20121:18 pmRNSDirector/PDMR Shareholding
19th Dec 20115:54 pmRNSDirectors' shareholdings and issue of equity
25th Nov 201112:00 pmRNSCash Placing
9th Nov 20117:00 amRNS2011 Annual Report and Accounts & Notice of AGM
11th Oct 20117:00 amRNSFinal Results
7th Oct 201112:43 pmRNSDirector/PDMR Shareholding
5th Oct 20117:00 amRNSHuman DNA Identification Collaboration
27th Sep 20117:00 amRNSGenedriveT passes first in-field Tuberculosis test
4th Aug 20117:00 amRNSPre Close Trading Update
30th Jun 201112:00 pmRNSDirector/PDMR Shareholding
28th Jun 20117:00 amRNSTuberculosis Diagnostic Collaboration
23rd Jun 20114:38 pmRNSHolding(s) in Company
19th May 20115:20 pmRNSHolding(s) in Company
19th Apr 201112:32 pmRNSHolding(s) in Company
19th Apr 201112:28 pmRNSHolding(s) in Company
8th Apr 20119:20 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.